FTC Statement on Appellate Court Decision Ordering Delisting of Teva Inhaler Patents
Today, the U.S. Court of Appeals for the Federal Circuit affirmed a lower district court order against pharmaceutical maker Teva requiring the drugmaker to delist several asthma inhaler patents from the Food and Drug Administration’s (FDA) Orange Book. The …